Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8780995 | Gynecologic Oncology Reports | 2018 | 4 Pages |
Abstract
SCCOPT is a rare aggressive malignancy with majority of the women having an overall survival of 2â¯years. There is no clear consensus for the diagnosis and optimal treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Emmanouil Kalampokas, Vijay Sharma, Tanja Gagliardi, Fiona Payne, Mahalakshmi Gurumurthy,